This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Roche Molecular Systems, Inc., Roche Diagnostics Operations, Inc.. Active years: 2014-2018.
Company Filing History:


Years Active: 2014-2018
Title: Michael Kubista: Innovator in RNA Quality Assessment
Introduction
Michael Kubista is a notable inventor based in Moelndal, Sweden. He has made significant contributions to the field of molecular biology, particularly in the assessment of RNA quality. With a total of 5 patents to his name, Kubista's work has advanced the methodologies used in RNA research.
Latest Patents
Among his latest patents, one focuses on methods for assessing RNA quality. This invention describes techniques and kits for evaluating RNA quality in samples, utilizing stable RNA as a reference that is resistant to nuclease degradation. Another significant patent involves a method for lysis and reverse transcription for mRNA quantification. This method includes several steps, such as cultivating adherent cells, lysing them with a chaotropic agent, and performing reverse transcription followed by amplification of the cDNA.
Career Highlights
Throughout his career, Michael Kubista has worked with prominent companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and Roche Diagnostics Operations, Inc. These experiences have allowed him to apply his innovative ideas in practical settings, contributing to advancements in molecular diagnostics.
Collaborations
Kubista has collaborated with several professionals in his field, including Linda Stroembom and Neven Zoric. These partnerships have fostered a collaborative environment that enhances research and development in RNA technologies.
Conclusion
Michael Kubista's contributions to RNA quality assessment and his innovative patents have made a significant impact in the field of molecular biology. His work continues to influence research methodologies and improve the understanding of RNA dynamics.